CTNND1 and glioma: In agreement with the published literature, we find that suppression of SFK activity with dasatinib in SF767 glioma cells inhibits p120 Y228 phosphorylation, Vav2 Y172 phosphorylation, and Rac1 activation, and blocks their directed migration in culture.